Financhill
Back

Cytokinetics Quote, Financials, Valuation and Earnings

Cytokinetics Price Quote

$54.71
+0.01 (+-2.22%)
(Updated: November 15, 2024 at 2:38 AM ET)

Cytokinetics Key Stats

Buy
53
Cytokinetics (CYTK) is a Buy

Day range:
$54.56 - $56.31
52-week range:
$30.68 - $110.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,868.03
P/B ratio:
0%

Volume:
896K
Avg. volume:
1.1M
1-year change:
59.52%
Market cap:
$6.6B
Revenue:
$7.5M
EPS:
$-5.38

How Much Does Cytokinetics Make?

Is Cytokinetics Growing As A Company?

  • What Is Cytokinetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.22%
  • What Is Cytokinetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Cytokinetics Stock Price Performance

  • Did Cytokinetics Stock Go Up Last Month?
    Cytokinetics share price went up by 0.37% last month
  • Did CYTK's Share Price Rise Over The Last Year?
    CYTK share price rose by 59.52% over the past 1 year

What Is Cytokinetics 52-Week High & Low?

Cytokinetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cytokinetics?

  • How Much Debt Does Cytokinetics Have?
    Total long term debt quarterly is $656M
  • How Much Cash Does Cytokinetics Have?
    Cash and short term investments quarterly total is $1B
  • What Is Cytokinetics’s Book Value Per Share?
    Book value per share is -0.12

Is Cytokinetics Cash Flow Positive?

  • What Is CYTK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$404.4M
  • What Is Cytokinetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.1B
  • What Is Cytokinetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$745.4M

Cytokinetics Return On Invested Capital

  • Is Management Doing A Good Job?
    CYTK return on invested capital is -142.05%
  • What Is Cytokinetics Return On Assets?
    ROA measures how assets are converting to revenues and is -54.04%
  • What Is CYTK Return On Equity?
    ROE is a measure of profitability and is 0%

Cytokinetics Earnings Date & Stock Price

  • What Is Cytokinetics's Stock Price Today?
    A single share of CYTK can be purchased today for 54.70
  • What Is Cytokinetics’s Stock Symbol?
    Cytokinetics trades on the nasdaq under the ticker symbol: CYTK
  • When Is Cytokinetics’s Next Earnings Date?
    The next quarterly earnings date for Cytokinetics is scheduled on February 27, 2025
  • When Is CYTK's next ex-dividend date?
    Cytokinetics's next ex-dividend date is November 15, 2024
  • How To Buy Cytokinetics Stock?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cytokinetics Competitors

  • Who Are Cytokinetics's Competitors?
    Below is a list of companies who compete with Cytokinetics or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Ocugen Inc (OCGN)
    • Sarepta Therapeutics Inc (SRPT)

Cytokinetics Dividend Yield

Cytokinetics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -9.26%
Revenue: 22.49% -60.77%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 82.67
Upside from Last Price: 51.13%

Major Shareholders

  • How many CYTK shares are owned by institutional investors?
    221.7M CYTK shares are owned by institutional investors
  • How many CYTK shares are owned by insiders?
    2M CYTK shares are owned by insiders